PMH16 DRUG EXPENDITURE, PRICE, AND UTILIZATION IN THE U.S. MEDICAID PROGRAM: AN EMPIRICAL TREND ANALYSIS FOR SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS) ANTIDEPRESSANTS FROM 1991 ...
May 1, 2020, 00:00
10.1016/j.jval.2020.04.637
https://www.valueinhealthjournal.com/article/S1098-3015(20)30825-1/fulltext
Title :
PMH16 DRUG EXPENDITURE, PRICE, AND UTILIZATION IN THE U.S. MEDICAID PROGRAM: AN EMPIRICAL TREND ANALYSIS FOR SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS) ANTIDEPRESSANTS FROM 1991 ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30825-1&doi=10.1016/j.jval.2020.04.637
First page :
Section Title :
Open access? :
No
Section Order :
10527